JP2010520251A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520251A5
JP2010520251A5 JP2009552166A JP2009552166A JP2010520251A5 JP 2010520251 A5 JP2010520251 A5 JP 2010520251A5 JP 2009552166 A JP2009552166 A JP 2009552166A JP 2009552166 A JP2009552166 A JP 2009552166A JP 2010520251 A5 JP2010520251 A5 JP 2010520251A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
halogen
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009552166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520251A (ja
JP4745446B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/052244 external-priority patent/WO2008107334A2/en
Publication of JP2010520251A publication Critical patent/JP2010520251A/ja
Publication of JP2010520251A5 publication Critical patent/JP2010520251A5/ja
Application granted granted Critical
Publication of JP4745446B2 publication Critical patent/JP4745446B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009552166A 2007-03-05 2008-02-25 Glyt−1阻害剤の合成 Active JP4745446B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07103485 2007-03-05
EP07103485.4 2007-03-05
PCT/EP2008/052244 WO2008107334A2 (en) 2007-03-05 2008-02-25 Process for the synthesis of glyt-1 inhibitors

Publications (3)

Publication Number Publication Date
JP2010520251A JP2010520251A (ja) 2010-06-10
JP2010520251A5 true JP2010520251A5 (show.php) 2010-12-09
JP4745446B2 JP4745446B2 (ja) 2011-08-10

Family

ID=39469606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009552166A Active JP4745446B2 (ja) 2007-03-05 2008-02-25 Glyt−1阻害剤の合成

Country Status (13)

Country Link
US (1) US7812161B2 (show.php)
EP (1) EP2131843B1 (show.php)
JP (1) JP4745446B2 (show.php)
KR (1) KR101143073B1 (show.php)
CN (1) CN101622000B (show.php)
AT (1) ATE532516T1 (show.php)
AU (1) AU2008223915B2 (show.php)
BR (1) BRPI0808570B8 (show.php)
CA (1) CA2678630C (show.php)
ES (1) ES2375585T3 (show.php)
IL (1) IL200323A (show.php)
MX (1) MX2009009065A (show.php)
WO (1) WO2008107334A2 (show.php)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5656474B2 (ja) 2010-06-28 2015-01-21 関東化学株式会社 脂肪族光学活性フルオロアルコールの製造方法
CN104628679B (zh) * 2013-11-08 2018-02-09 江苏恩华药业股份有限公司 Bitopertin的合成方法及其中间体
CN106397312B (zh) * 2015-07-31 2020-03-24 广东东阳光药业有限公司 一种制备glyt-1抑制剂的方法
EP4087570A4 (en) 2020-01-09 2024-04-03 Disc Medicine, Inc. METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT INHIBITORS
EP4229051A1 (en) 2020-10-13 2023-08-23 Boehringer Ingelheim International GmbH Process of reworking
CN119768399A (zh) 2022-08-24 2025-04-04 勃林格殷格翰国际有限公司 GlyT-1抑制剂的可规模化制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
US4480102A (en) * 1982-07-23 1984-10-30 The Dow Chemical Company 2,3-Difluoro-5-(trifluoromethyl)pyridine and methods of making and using the same
IE62792B1 (en) * 1988-11-24 1995-03-08 Akzo Nv Pharmaceutical composition containing 1-(mono- or bis (Trifluoromethyl)-2-pyridinyl) piperazines
DE4235155A1 (de) * 1992-10-19 1994-04-21 Basf Ag Verfahren zur Herstellung von Methylsulfonylbenzoesäuren
KR20010042851A (ko) * 1998-04-20 2001-05-25 후지야마 아키라 cGMP 포스포디에스터라제 억제자로서의 안트라닐산유도체
DE10112040A1 (de) * 2001-03-14 2002-10-02 Aventis Pharma Gmbh Verbessertes Verfahren zur Herstellung von Sulfonylcarboxamidderivaten
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
CN1867554B (zh) * 2003-08-11 2011-07-06 弗·哈夫曼-拉罗切有限公司 具有邻-取代的苯基的哌嗪及其作为glyt1抑制剂的用途
AU2005313581B2 (en) * 2004-12-09 2011-06-09 F. Hoffmann-La Roche Ag Phenyl-piperazin methanone derivatives
CA2593453A1 (en) * 2005-01-06 2006-07-13 F. Hoffmann-La Roche Ag Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
ATE472327T1 (de) * 2005-01-07 2010-07-15 Hoffmann La Roche Ä4-(heteroaryl)piperazin-1-ylü-(2,5-substituier e phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
MX2008000260A (es) * 2005-07-08 2008-03-24 Hoffmann La Roche Reduccion asimetrica de 1,1,1-trifluoroacetona.

Similar Documents

Publication Publication Date Title
JP2010520251A5 (show.php)
JP2010531876A5 (show.php)
JP2008063319A5 (show.php)
RU2016124161A (ru) Процессы приготовления производных дигидропиримидина и их промежуточных соединений
JP2006519818A5 (show.php)
JP2012506425A5 (show.php)
JP2010513494A5 (show.php)
JP2009533369A5 (show.php)
JP2009521545A5 (show.php)
JP2009515988A5 (show.php)
JP2014532054A5 (show.php)
JP2012526086A5 (show.php)
JP2009514988A5 (show.php)
JP2009527517A5 (show.php)
JP2011524871A5 (show.php)
JP2015516959A5 (show.php)
CN106831737A (zh) 维帕他韦及其衍生物的制备
JP2008520662A5 (show.php)
JP2006526587A5 (show.php)
CN102675181B (zh) 一种左乙拉西坦的制备方法
CN101146810A (zh) 制备1-取代的1H-咪唑并[4,5-c]喹啉-4-胺化合物的方法及其中间体
JP2007506659A5 (show.php)
JP2007045816A5 (ja) カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法
JP2007048462A5 (show.php)
JP6228210B2 (ja) フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法